
MEI Pharma
OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.
| Headquarter | 489 5th Avenue, 28th Floor New York City, NY United States of America |
|---|---|
| Website | ohrpharmaceutical.com |
| Founding Date | 2009 |
| Tel | (212) 682-8452 |
| Company Status | Public |
| Stock | OHRP |

Jason Slakter CEO / President
Jason Slakter serves as the CEO / President of OHR Pharmaceutical.

Samuel Backenroth Chief Financial Officer and Vice President of Business Development
Mr. Samuel Backenroth, also known as Sam, has been Chief Financial Officer at Ohr Pharmaceutical, Inc. and Vice...

Peter K. Kaiser M.D. Head of Product Development
Dr. Peter K. Kaiser, M.D. has been Head of Product Development at Ohr Pharmaceutical, Inc. since May 18, 2016. Dr....

Marlene Modi Ph.D. Head of Preclinical and Regulatory Affairs
Dr. Marlene Modi, Ph.D., has been Head of Preclinical and Regulatory Affairs at Ohr Pharmaceutical, Inc., since May 18,...

Glenn L. Stoller M.D. Chief Scientific Officer
Dr. Glenn L. Stoller, M.D., has been the Chief Scientific Officer at Ohr Pharmaceutical, Inc., since June 2, 2014. Dr....

No Recent Jobs found for OHR Pharmaceutical on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is OHR Pharmaceutical address?
OHR Pharmaceutical location is at 489 5th Avenue, 28th Floor
Who are OHR Pharmaceutical competitors?
OHR Pharmaceutical main competitors are MEI Pharma
Who is OHR Pharmaceutical leadership?
Samuel Backenroth, Peter K. Kaiser M.d. & Marlene Modi Ph.d. are part of OHR Pharmaceutical leadership, Jason Slakter is the CEO